Publication | Closed Access

Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB–IVM1a melanoma: a randomized, open-label, phase 2 trial

Surgical OncologyMedicineMelanomaSurgeryNeoadjuvant Talimogene LaherparepvecCancer TreatmentOncologyRadiation OncologySurgery Versus Surgery